相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction
Dan Hu et al.
HEART RHYTHM (2007)
Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin
R. S. Duncan et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Raloxifene inhibits transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes
Hui Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes
Akshay Gupta et al.
AMERICAN HEART JOURNAL (2007)
1,4-Dihydroindeno[1,2-c]pyrazoles with acetylenic side chains as novel and potent multitargeted receptor tyrosine kinase inhibitors with low affinity for the hERG ion channel
Jurgen Dinges et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers
C. B. Eap et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
A common SCN5A variant alters the responsiveness of human sodium channels to class I antiarrhythmic agents
Mossaab Shuraih et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2007)
Blockade of HERG human K+ channels and I-Kr of guinea-pig cardiomyocytes by the antipsychotic drug clozapine
So-Young Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports
Dan Justo et al.
MYCOSES (2006)
Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome
Kevin Vernooy et al.
HEART RHYTHM (2006)
Effects of antipsychotic drugs on Ito, INa, Isus, IK1, and hERG:: QT prolongation, structure activity relationship, and network analysis
William J. Crumb et al.
PHARMACEUTICAL RESEARCH (2006)
Brugada syndrome and anesthetic management
Roger Cordery et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2006)
α1-Acid glycoprotein reverses cocaine-induced sodium channel blockade in cardiac myrocytes
YL Ma et al.
TOXICOLOGY (2006)
A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y
LD Plant et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction
CR Bezzina et al.
CIRCULATION (2006)
Block of hERG channel by ziprasidone: Biophysical properties and molecular determinants
Z Su et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome
AO Verkerk et al.
CARDIOVASCULAR RESEARCH (2005)
Rote of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes
C Antzelevitch
HEART RHYTHM (2005)
Acquired forms of the Brugada syndrome
W Shimizu
JOURNAL OF ELECTROCARDIOLOGY (2005)
Dopamine modulation of two delayed rectifier potassium currents in a small neural network
M Gruhn et al.
JOURNAL OF NEUROPHYSIOLOGY (2005)
Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more?
PG Meregalli et al.
CARDIOVASCULAR RESEARCH (2005)
Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks
A Burke et al.
CIRCULATION (2005)
Diphenhydramine overdose and Brugada sign
B López-Barbeito et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2005)
Pentamidine reduces hERG expression to prolong the QT interval
JS Cordes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Risperidone-induced action potential prolongation is attenuated by increased repolarization reserve due to concomitant block of ICa,L
T Christ et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
Mouse model of SCN5A-linked hereditary Lenegre's disease -: Age-related conduction slowing and myocardial fibrosis
A Royer et al.
CIRCULATION (2005)
Pentamidine-induced long QT syndrome and block of hERG trafficking
YA Kuryshev et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Delay in right ventricular activation contributes to Brugada syndrome
R Tukkie et al.
CIRCULATION (2004)
Torsades de pointes associated with fluoroquinolones: Importance of concomitant risk factors
K Amankwa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells
M Traebert et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Oral erythromycin and the risk of sudden death from cardiac causes
WA Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Risperidone reduces K+ currents in human atrial myocytes and prolongs repolarization in human myocardium
P Gluais et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Mechanisms of arsenic-induced prolongation of cardiac repolarization
E Ficker et al.
MOLECULAR PHARMACOLOGY (2004)
Mesoridazine: an open-channel blocker of human ether-a-go-go-related gene K+ channel
Z Su et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5 - sildenafil, tadalafil, and vardenafil
RD Sarazan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Proarrhythmia with non-antiarrhythmics - A review
CA Albrecht
CARDIOLOGY (2004)
Dopamine receptor agonists differ in their actions on cardiac ion channels
RS Hurst et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The antipsychotic drug chlorpromazine inhibits HERG potassium channels
D Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current
B Drolet et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
What clinicians should know about the QT interval
SM Al-Khatib et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Genetic control of sodium channel function
HL Tan et al.
CARDIOVASCULAR RESEARCH (2003)
Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac)
T Kobayashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system
CR Bezzina et al.
CIRCULATION RESEARCH (2003)
Closing and inactivation potentiate the cocaethylene inhibition of cardiac sodium channels by distinct mechanisms
ME O'Leary et al.
MOLECULAR PHARMACOLOGY (2003)
Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel
SJC Stanat et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Induced QT prolongation and torsades de pointes
YG Yap et al.
HEART (2003)
SNPS1103Y in the cardiac sodium channel gene SCN5A is associated with cardiac arrhythmias and sudden death in a white family
S Chen et al.
JOURNAL OF MEDICAL GENETICS (2002)
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: Fast phase 3 repolarization prevents early afterdepolarizations and Torsade de Pointes
P Milberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Drug-induced Long-QT syndrome associated with a subclinical SCN5A mutation
N Makita et al.
CIRCULATION (2002)
Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia
I Splawski et al.
SCIENCE (2002)
Overdose of cyclic antidepressants and the Brugada syndrome
D Goldgran-Toledano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a
GA Papadatos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes
P Yang et al.
CIRCULATION (2002)
Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents
HJ Witchel et al.
FEBS LETTERS (2002)
Rates of Torsades de Pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin
R Frothingham
PHARMACOTHERAPY (2001)
A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia
T Hagiwara et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2001)
Asymptomatic Brugada Syndrome case unmasked during dimenhydrinate infusion
A Pastor et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2001)
Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion
J Ortega-Carnicer et al.
JOURNAL OF ELECTROCARDIOLOGY (2001)
The cardiac sodium channel: Gating function and molecular pharmacology
JR Balser
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Transient ST segment elevation in right precordial leads induced by psychotropic drugs: Relationship to the Brugada syndrome
F Rouleau et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2001)
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction:: a randomised trial
L Kober et al.
LANCET (2000)
Effects of amphetamine on calcium and potassium currents in rat heart
O Casis et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
The Long QT Syndromes: Genetic basis and clinical implications
CE Chiang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias
C Napolitano et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2000)
From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels
WA Catterall
NEURON (2000)
Cardiotoxic effects of fenfluramine hydrochloride on isolated cardiac preparations and ventricular myocytes of guinea-pigs
S Rajamani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
